{"entity":{"type":"insider","cik":"0001874199","url":"/insider/0001874199","json_url":"/insider/0001874199.json","name":"Washburn Theodore James Jr.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":19,"first":"2022-02-16","last":"2026-03-05","span_basis":"filed_date"},"name_variants":[{"name":"Washburn Theodore James Jr.","source":"filing","n_filings":19,"first_seen":"2022-02-16","last_seen":"2026-03-05"}],"transactions":[{"id":5881151,"accession":"0001439222-26-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-26-000046","line_url":"/filing/0001439222-26-000046#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5272.0,"shares_display":"5,272","price_per_share":28.88,"price_display":"28.88","price_state":"stated","total_value":152255.36,"total_display":"152,255.36","total_whole":"152,255","shares_owned_after":868.0,"shares_owned_after_display":"868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-05","scope":"insider"},{"id":5894786,"accession":"0001439222-26-000034","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001439222-26-000034","line_url":"/filing/0001439222-26-000034","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2223.0,"shares_display":"2,223","price_per_share":28.96,"price_display":"28.96","price_state":"stated","total_value":64378.08,"total_display":"64,378.08","total_whole":"64,378","shares_owned_after":6140.0,"shares_owned_after_display":"6,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider","n_lines":3},{"id":4435909,"accession":"0001439222-25-000102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-25-000102","line_url":"/filing/0001439222-25-000102#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8546.0,"shares_display":"8,546","price_per_share":36.87,"price_display":"36.87","price_state":"stated","total_value":315091.02,"total_display":"315,091.02","total_whole":"315,091","shares_owned_after":868.0,"shares_owned_after_display":"868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-09","scope":"insider"},{"id":4435894,"accession":"0001439222-25-000011","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001439222-25-000011","line_url":"/filing/0001439222-25-000011","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1655.0,"shares_display":"1,655","price_per_share":35.54,"price_display":"35.54","price_state":"stated","total_value":58818.7,"total_display":"58,818.70","total_whole":"58,819","shares_owned_after":9414.0,"shares_owned_after_display":"9,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider","n_lines":3},{"id":4040409,"accession":"0001439222-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000004","line_url":"/filing/0001439222-25-000004#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2272.0,"shares_display":"2,272","price_per_share":34.39,"price_display":"34.39","price_state":"stated","total_value":78134.08,"total_display":"78,134.08","total_whole":"78,134","shares_owned_after":5437.0,"shares_owned_after_display":"5,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-05","scope":"insider"},{"id":2216640,"accession":"0001439222-24-000144","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-24-000144","line_url":"/filing/0001439222-24-000144#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":772.0,"shares_display":"772","price_per_share":56.09,"price_display":"56.09","price_state":"stated","total_value":43301.48,"total_display":"43,301.48","total_whole":"43,301","shares_owned_after":813.0,"shares_owned_after_display":"813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-08","filed_date":"2024-11-13","scope":"insider"},{"id":2629205,"accession":"0001439222-24-000071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-24-000071","line_url":"/filing/0001439222-24-000071#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1362.0,"shares_display":"1,362","price_per_share":44.39,"price_display":"44.39","price_state":"stated","total_value":60459.18,"total_display":"60,459.18","total_whole":"60,459","shares_owned_after":1524.0,"shares_owned_after_display":"1,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider"},{"id":2866391,"accession":"0001439222-24-000056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-24-000056","line_url":"/filing/0001439222-24-000056#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1913.0,"shares_display":"1,913","price_per_share":31.75,"price_display":"31.75","price_state":"stated","total_value":60737.75,"total_display":"60,737.75","total_whole":"60,738","shares_owned_after":2886.0,"shares_owned_after_display":"2,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-07","scope":"insider"},{"id":2866387,"accession":"0001439222-24-000050","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001439222-24-000050","line_url":"/filing/0001439222-24-000050","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1214.0,"shares_display":"1,214","price_per_share":32.57,"price_display":"32.57","price_state":"stated","total_value":39539.98,"total_display":"39,539.98","total_whole":"39,540","shares_owned_after":4799.0,"shares_owned_after_display":"4,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-05","scope":"insider","n_lines":2},{"id":2478001,"accession":"0001439222-24-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-24-000037","line_url":"/filing/0001439222-24-000037#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":504.0,"shares_display":"504","price_per_share":26.63,"price_display":"26.63","price_state":"stated","total_value":13421.52,"total_display":"13,421.52","total_whole":"13,422","shares_owned_after":2741.0,"shares_owned_after_display":"2,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-22","scope":"insider"},{"id":2055299,"accession":"0001439222-24-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000026","line_url":"/filing/0001439222-24-000026#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":273.0,"shares_display":"273","price_per_share":25.14,"price_display":"25.14","price_state":"stated","total_value":6863.22,"total_display":"6,863.22","total_whole":"6,863","shares_owned_after":3245.0,"shares_owned_after_display":"3,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-14","filed_date":"2024-02-14","scope":"insider"},{"id":7811830,"accession":"0001439222-23-000121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-23-000121","line_url":"/filing/0001439222-23-000121#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2918.0,"shares_display":"2,918","price_per_share":25.3927,"price_display":"25.39","price_state":"stated","total_value":74095.8986,"total_display":"74,095.90","total_whole":"74,096","shares_owned_after":2741.0,"shares_owned_after_display":"2,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-07","filed_date":"2023-08-09","scope":"insider"},{"id":8481618,"accession":"0001439222-23-000113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-23-000113","line_url":"/filing/0001439222-23-000113#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1232.0,"shares_display":"1,232","price_per_share":26.26,"price_display":"26.26","price_state":"stated","total_value":32352.32,"total_display":"32,352.32","total_whole":"32,352","shares_owned_after":5659.0,"shares_owned_after_display":"5,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-02","scope":"insider"},{"id":8366496,"accession":"0001439222-23-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-23-000053","line_url":"/filing/0001439222-23-000053#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":504.0,"shares_display":"504","price_per_share":24.29,"price_display":"24.29","price_state":"stated","total_value":12242.16,"total_display":"12,242.16","total_whole":"12,242","shares_owned_after":2741.0,"shares_owned_after_display":"2,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-07","scope":"insider"},{"id":8366491,"accession":"0001439222-23-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-23-000028","line_url":"/filing/0001439222-23-000028#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233.0,"shares_display":"233","price_per_share":27.21,"price_display":"27.21","price_state":"stated","total_value":6339.93,"total_display":"6,339.93","total_whole":"6,340","shares_owned_after":2668.0,"shares_owned_after_display":"2,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-21","scope":"insider"},{"id":8632080,"accession":"0001439222-23-000026","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001439222-23-000026","line_url":"/filing/0001439222-23-000026#line-3","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":504.0,"shares_display":"504","price_per_share":28.59,"price_display":"28.59","price_state":"stated","total_value":14409.36,"total_display":"14,409.36","total_whole":"14,409","shares_owned_after":2901.0,"shares_owned_after_display":"2,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-16","scope":"insider"},{"id":6327457,"accession":"0001439222-22-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-22-000025","line_url":"/filing/0001439222-22-000025#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":108.0,"shares_display":"108","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":3240.0,"total_display":"3,240.00","total_whole":"3,240","shares_owned_after":2549.0,"shares_owned_after_display":"2,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-25","filed_date":"2022-03-01","scope":"insider"},{"id":6482997,"accession":"0001439222-22-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-22-000013","line_url":"/filing/0001439222-22-000013#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233.0,"shares_display":"233","price_per_share":30.81,"price_display":"30.81","price_state":"stated","total_value":7178.73,"total_display":"7,178.73","total_whole":"7,179","shares_owned_after":2549.0,"shares_owned_after_display":"2,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-16","filed_date":"2022-02-18","scope":"insider"},{"id":6090762,"accession":"0001439222-22-000009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001439222-22-000009","line_url":"/filing/0001439222-22-000009#line-3","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001874199","owner_name":"Washburn Theodore James Jr.","owner_display_name":"Washburn Theodore James Jr.","owner_url":"/insider/0001874199","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":504.0,"shares_display":"504","price_per_share":31.25,"price_display":"31.25","price_state":"stated","total_value":15750.0,"total_display":"15,750.00","total_whole":"15,750","shares_owned_after":2782.0,"shares_owned_after_display":"2,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-14","filed_date":"2022-02-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Officer (Principal Accounting Officer)","n_filings":19,"first_seen":"2022-02-16","last_seen":"2026-03-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001874199","retrieved_at":"2026-08-25T08:36:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}